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Estimating the time of delivery is of high clinical importance because pre- and postterm deviations
are associated with complications for the mother and her offspring. However, current estimations
are inaccurate. As pregnancy progresses toward labor, major transitions occur in fetomaternal
immune, metabolic, and endocrine systems that culminate in birth. The comprehensive
characterization of maternal biology that precedes labor is key to understanding these
physiological transitions and identifying predictive biomarkers of delivery. Here, a longitudinal
study was conducted in 63 women who went into labor spontaneously. More than 7000 plasma
analytes and peripheral immune cell responses were analyzed using untargeted mass spectrometry,
aptamer-based proteomic technology, and single-cell mass cytometry in serial blood samples
collected during the last 100 days of pregnancy. The high-dimensional dataset was integrated into
a multiomic model that predicted the time to spontaneous labor [R = 0.85, 95% confidence interval
(CI) [0.79 to 0.89], P = 1.2 × 10−40, N = 53, training set; R = 0.81, 95% CI [0.61 to 0.91], P = 3.9
× 10−7, N = 10, independent test set]. Coordinated alterations in maternal metabolome, proteome,
and immunome marked a molecular shift from pregnancy maintenance to prelabor biology 2 to 4
weeks before delivery. A surge in steroid hormone metabolites and interleukin-1 receptor type 4
that preceded labor coincided with a switch from immune activation to regulation of inflammatory
responses. Our study lays the groundwork for developing blood-based methods for predicting the
day of labor, anchored in mechanisms shared in preterm and term pregnancies.

INTRODUCTION
Author Manuscript

During human pregnancy, the onset of labor is precisely timed to ensure the delivery of a
healthy newborn. However, what determines the timing of parturition is not clearly
understood. The ability to accurately predict the timing of labor is of high clinical
importance because preterm (<37 weeks of gestation) or postterm (>42 weeks of gestation)
deviations are associated with complications for the mother and her offspring (1, 2).
Existing methods for predicting the day of labor perform poorly (3–5). In current clinical
practice, the estimate day of delivery (EDD) is calculated on the basis of the first day of the

Sci Transl Med. Author manuscript; available in PMC 2021 May 20.

Stelzer et al.

Page 3

Author Manuscript

last menstrual period (LMP) and assumes a gestational length of 40 weeks (6, 7). The
gestational age (GA) and EDD are further determined by the first accurate ultrasound
examination (8). Although they are useful for managing the pregnancy, the EDD and GA are
not accurate predictors for when labor will actually occur because most pregnancies deviate
from the norm of 40 weeks of gestational duration. To advance clinical decision-making,
further estimation approaches including predictive biomarkers are critically needed to better
predict the actual labor onset, leading to delivery in healthy and pathological pregnancies.

Author Manuscript

A comprehensive characterization of the biological processes that precede spontaneous labor
is a key step for the identification of predictive biomarkers. The maintenance of pregnancy
relies on finely tuned adaptations (9–11), which are readily detectable in maternal blood
using high-content metabolomic, proteomic, and single-cell cytometric technologies (12–
17). At the onset of labor, a major transition occurs in the fetomaternal physiology that
culminates in the delivery of the fetus, including the breakdown of fetomaternal immune
tolerance by immune infiltration into fetal membranes and the placenta (18, 19), endocrine
changes (20, 21), rupture of fetal membranes (22), cervical dilation, and augmentation of
uterine contractility (23).

Author Manuscript

The timing of systemic molecular and cellular events that mark the transition from
pregnancy maintenance to parturition, which begins with labor contractions and/or
spontaneous rupture of membranes (24), is ill-defined. Prior studies have provided important
information with regard to systemic maternal adaptations that track GA during pregnancy
(13, 15–17, 25). However, to understand the biological transition to labor, studies are needed
that specifically examine labor biology in relation to spontaneous labor onset, rather than in
relation to the estimated GA. Limitations in either study design, such as inclusion of
medically induced labor cases, or technology, such as the limited coverage of immune
system–wide adaptations, have precluded a comprehensive analysis of biologic events
preceding spontaneous labor and delivery.

Author Manuscript

In this study, we combined an untargeted mass spectrometry approach (26) with an aptamerbased technology (27) to quantify the concentrations of 4846 metabolomic and proteomic
analytes in longitudinally collected plasma samples during the 100-day period preceding
spontaneous labor onset. In parallel, we used a single-cell mass cytometry immunoassay to
quantify the dynamic changes in the distribution and intracellular signaling responses of all
major innate and adaptive peripheral immune cells (2296 features). The analysis generated
three high-dimensional omic datasets. We applied a stacked generalization (SG) algorithm to
the multiomic dataset to build and independently validate an integrated model that predicted
the time to labor (TL). Model component trajectories revealed precisely timed alterations
that marked a transition from pregnancy maintenance to prelabor biology. Our findings and
predictive modeling approach can serve to identify elements of a common pathway that
precedes labor in term as well as pre- or postterm pregnancies.
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RESULTS
Maternal metabolome, proteome, and immunome are assessed in the 100 days preceding
the day of labor

Author Manuscript

One-hundred twelve pregnant women receiving routine antepartum care at the Lucile
Packard Children’s Hospital in Stanford, CA, USA, were enrolled during their second or
third trimester of pregnancy. After exclusion of patients who did not meet the inclusion
criteria, such as medical induction of labor (see Materials and Methods), an analysis was
performed on samples from 53 patients (training cohort) with spontaneous labor
contractions. The day of labor for this study is defined as the day of admission for
spontaneous labor (contractions occurring at least every 5 min, lasting >1 min, and
associated with cervical change). All patients in the training cohort were in stage I labor on
the day of labor at the time of diagnosis, among which 73.6% were in the latent phase and
delivered within 11 hours [interquartile range (IQR) [5, 18] hours]. The remaining 26.4%
were in the active phase of labor and delivered within 4 hours (IQR [2, 10] hours). The
difference between the day of labor and day of delivery ranged from 0 to 1 day (median = 0;
SD = 0.23; range [0, 1] days). Five women in the training cohort delivered preterm [34
weeks + 0 days (34+0) to <37 weeks of gestation]. An independent analysis was performed
on samples from 10 additional patients (test cohort), who had spontaneous labor (N = 5) or
spontaneous rupture of membranes (N = 5). Patient demographics including labor and
delivery, as well as ante- and peripartum parameters are shown in Table 1.

Author Manuscript
Author Manuscript

For each study participant, serial blood samples [median of three samples (plasma and
whole blood) per patient, range [1, 3]] were collected during the last 100 days before labor
(Fig. 1A). The approach leveraged the interindividual variabilities in sample collection time
to define a continuous variable, the TL, which describes the difference between the day of
sampling and the day of labor. In the aggregated sample cohort of all patients, the TL was
distributed with near daily resolution across the last 100 days of pregnancy with a median
time of blood sampling of 36 days (~5 weeks) before the day of labor. The plasma
concentration of 3529 metabolites and 1317 proteins were quantified using a highthroughput untargeted mass spectrometry and an aptamer-based proteomic platform,
respectively (Fig. 1B). Using a 46-parameter mass cytometry assay (table S1), a total of
2296 single-cell immune features were extracted from each sample including the frequencies
of 41 immune cell subsets, representing major innate and adaptive populations, endogenous
intracellular activities such as phosphorylation states of 11 signaling proteins, and capacities
of each cell subset to respond to a series of receptor-specific immune challenges
[lipopolysaccharide (LPS), interferon-α (IFN-α), granulocyte-macrophage colonystimulating factor (GM-CSF), and a combination of interleukin-2 (IL-2), IL-4, and IL-6].
Multiomic modeling of the maternal interactome predicts labor onset
The combined metabolome, proteome, and immunome datasets produced 7142 features per
sample. Features were visualized with three correlation networks, highlighting intraomic
(within-dataset) correlations across the last 100 days before the day of labor (Fig. 2, A to C).
A single chord diagram highlighted interomic (between-dataset) correlations between
features from two different datasets (Fig. 2, D and E), after controlling to a false discovery
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rate (FDR) of 0.05 (Spearman R > 0.46) computed from the distribution of correlation
between randomly generated features (Fig. 2D). Individual biological systems were tightly
orchestrated because 99% of all omic correlations were found in feature pairs belonging to
the same dataset (Fig. 2, A to C).

Author Manuscript

Correlations between the three biological systems included 3995 weak (R = 0.46 to 0.59),
596 moderate (R = 0.6 to 0.79), and 21 strong (R = 0.8 to 1.0) interomic correlations (Fig. 2,
E and F), revealing an interactome of late pregnancy. Of all interomic correlations (R > 0.46,
FDR < 0.05), 80% were observed between the metabolome and proteome, 4% between the
immunome and proteome, and 16% between the immunome and metabolome (Fig. 2F).
Overall, the multimodal analysis of plasma analytes and peripheral blood immune cells
measured during pregnancy revealed a concerted behavior between the metabolomic,
proteomic, and immunologic systems. The interactome analysis did not account for the
timing of omic measurements, such that observed correlations were not enriched for
interactions temporally linked to the time in pregnancy. However, the analysis highlighted
the interconnected nature of the multiomic dataset, justifying the need for an integrated
approach to identify biologically relevant components predictive of the TL.

Author Manuscript

Peripheral blood metabolic, proteomic, and immunologic events informed an integrated
approach to predict the TL. Here, multivariate least absolute shrinkage and selection
operator (LASSO) linear regression models were first individually built for each omic
dataset and then integrated into a single model by SG. An advantage of the SG method is
that differences in size and modularity of individual omic modalities are accounted for to
prevent datasets of higher dimensions (such as the metabolome) to overwhelm the integrated
model (Fig. 3A) (14, 28). The SG model predicted the TL from the measurement of
metabolic, proteomic, and immunologic features with high accuracy [R = 0.85, 95%
confidence interval (CI) [0.79 to 0.89], P = 1.2 × 10−40, root mean square error (RMSE) =
17.7 days, N = 53] (Fig. 3B). Statistical significance was established using a cross-validation
method that accounts for the high dimensionality of the data. The generalizability of the SG
model was prospectively tested in an independent cohort of 10 additional women (R = 0.81,
95% CI [0.61 to 0.91], P = 3.9 × 10−7, RMSE = 17.4 days) (Fig. 3C).

Author Manuscript

Five of the 53 patients included in the training cohort experienced spontaneous preterm labor
(GA at delivery < 37 weeks). Although comparing term and preterm labor was not a primary
aim of the study, the presence of these five patients questioned whether the integrated SG
approach would generalize to predict the TL when labor occurred preterm. A new model
trained on a subcohort of patients with term labor successfully predicted the TL for patients
with preterm labor (R = 0.67, 95% CI [0.21 to 0.86], P = 8.8 × 10−3, RMSE = 27.3 days; fig.
S1, A to D). In addition, there was a strong overlap between the most informative features of
the original model (including term and preterm patients) and the term-only model (fig. S1, E
to G; R = 0.68 to 0.78, Spearman correlation in bootstrap feature ranking between the two
models). The results suggest that the SG model generalized to the prediction of the TL for
both term and preterm labor. The data also confirm that the SG model built on the entire
patient cohort was not driven by a preterm-specific prelabor biology. A confounder analysis
further established that the prediction accuracy was not influenced by other clinical or
demographic variables [including race, body mass index (BMI), and major comorbidities;
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table S2]. In summary, our assessment of maternal circulating factors in the peripheral blood
provided an accurate prediction for the timing of labor that was independent of the GA
based on EDD.
Trajectories of metabolome, proteome, and immunome reveal alterations in prelabor
dynamics

Author Manuscript

To facilitate the biological interpretation of the multivariate SG model, we focused on the
model features that contributed most to the prediction of the TL (selected using a bootstrap
and ranking approach; see Materials and Methods). These features included 12
metabolomic, 18 proteomic, and 15 immune cell features (Fig. 3D and table S3) and formed
a correlation network that segregated into two clusters (Fig. 3E). For each cluster, enriched
proteomic and metabolomic pathways were identified using the Fisher’s test (29) and the
hypergeometric test (30), respectively. The lower cluster was enriched for metabolic features
representing steroid hormone biosynthesis, and pentose and glucuronate interconversions
(carbohydrate metabolism) that clustered with innate and adaptive immune cell responses to
IFN-α stimulation [including phosphorylated signal transducer and activator of transcription
1 (pSTAT1) and phosphorylated mitogen-activated protein kinase–activated protein kinase
(pMK2) in dendritic cells (DCs), natural killer (NK) cells, and T cell subsets] (Fig. 3E). The
upper cluster contained metabolic features enriched for tryptophan metabolism and proteins
representing glycoprotein metabolic pathways that clustered with various immune cell
features, including granulocyte frequencies, signaling responses to GM-CSF in non-classical
monocytes (ncMCs) and basal pMK2 signaling in T cell subsets (Fig. 3E).

Author Manuscript

The pathway enrichment analysis provided a snapshot of key biological systems temporally
linked to the TL. To examine the dynamic behavior of biological events predictive of the TL,
individual model features were plotted over time (Fig. 4, figs. S2 to S4, and table S3).
Classifying the dynamic behavior of each feature revealed three general trajectory patterns
on the basis of the goodness of fit of a pattern-fitting model (Fig. 4A and table S4): linear
progression (degree 1; Fig. 4, B to D) or quadratic progression, including accelerating
(surging of an increasing or decreasing pattern over time) (degree 2a; Fig. 4, E to G) or
decelerating (plateauing of an increasing or decreasing pattern over time) (degree 2b; Fig. 4,
H to J) progression (table S4). We plotted the distribution of trajectory patterns across all
datasets. The resulting plot (Fig. 4K) showed a remarkable overlap of the behavior of
metabolomic and proteomic model features, which were predominantly classified as degree
1 (constant rate). In contrast, immune cell trajectories predominantly followed a degree 2b
(decelerating) pattern.

Author Manuscript

Degree 1 trajectories highlighted biological processes progressing linearly throughout the
last 100 days of pregnancy until labor (Fig. 4, B to D). For example, the plasma
concentration of an isomer of cortisol, strongly correlating with cortisol (Spearman R = 0.7;
Materials and Methods), increased steadily from TL −100 to labor onset (Fig. 4B),
recapitulating known steroid changes occurring throughout pregnancy (31, 32). Similarly,
proteins expressed by fetal membranes constantly increased throughout the 100 days before
labor, such as plexin-B2 (PLXB2) (33) and discoidin domain receptor-1 (DDR1) (fig. S3)
(34). In contrast, Angiopoietin-2, a protein that contributes to placental vascular
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development, decreased at a constant rate throughout the study period (Fig. 4C) (35, 36). In
addition to the many proteomic and metabolomic model features with constant pattern
trajectories, accelerating (degree 2a) or decelerating (degree 2b) trajectories denoted
important prelabor alterations of the maternal metabolome and proteome (Fig. 4, E, F, H,
and I).

Author Manuscript

Among the most informative degree 2 metabolomic features were isomers of 17hydroxyprogesterone (17-OHP) and 17-hydroxypregnenolone sulfate, an upstream substrate
for the production of 17-OHP. The isomers of 17-OHP correlate with 17-OHP, suggesting
that they have similar biological functions and belong to similar pathways (Materials and
Methods). Plasma concentrations of these features increased in accelerated fashion within
the last 30 days before the day of labor (Fig. 4E and fig. S2). Whereas this finding confirms
known progesterone biology in the late third trimester (37, 38), our data provide additional
temporal information showing that a surge in 17-OHP, one of the most informative features
of the predictive model, is tightly linked to the timing of labor. Furthermore, metabolites
with degree 2b trajectories included pregnenolone sulfate (39), which showed decelerating
behavior, stagnating around 30 days before the day of labor (Fig. 4H).

Author Manuscript

Among the most informative degree 2 proteomic features of the predictive model were
trajectories whose accelerating or decelerating patterns pointed toward important prelabor
alterations in placental biology, coagulation, and inflammation. The most informative degree
2a proteomic feature was IL-1 receptor type 4 (IL-1R4), the soluble inhibitory receptor of
the proinflammatory cytokine IL-33. IL-1R4 plasma concentration surged during the last 30
days before labor (Fig. 4F and fig. S3). The data complement prior studies showing an
elevated concentration of IL-1R4 during the third trimester of pregnancy (40, 41). Surging
concentrations of IL-1R4 observed in the systemic circulation may counteract the
proinflammatory effects of IL-33, potentially released upon mechanical uterine distension
and in the context of the local inflammation occurring at the fetomaternal interface (42, 43).
Hence, IL-1R4 may be an important regulator of inflammation during the late phase of
pregnancy.

Author Manuscript

Also surging with approaching labor (degree 2a) were two proteins highly expressed by the
placenta, Activin-A and sialic acid binding immunoglobulin-like lectin–6 (Siglec-6) (fig.
S3). In contrast, the trajectory of antithrombin III (ATIII), an endogenous anticoagulant (44),
negatively accelerated during the last 30 days before the day of labor (fig. S3). Soluble
tunica interna endothelial cell kinase–2 (sTie-2), a regulator of angiopoietin availability for
vasculogenesis (45), displayed a decelerating trajectory (Fig. 4I). Overall, together with the
constantly rising concentrations of fetal membrane–derived PLXB2 and DDR1 (fig. S3), the
coordinated trajectories of angiogenic factors sTie-2, Angiopoietin-2 (Fig. 4C), and vascular
endothelial growth factor 121 (VEGF121) as well as Activin-A, and Siglec-6 (fig. S3)
suggest that these proteins are integral components of a plasma fetoplacental signature that
portends the impending day of labor.
Plasma metabolites and proteins form the interactive environment for circulating immune
cells. Immune cell trajectories predominantly followed a decelerating pattern (Fig. 4, D, G,
and J), in contrast to accelerating or constantly increasing plasma analyte trajectories (Fig.
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4K). Granulocyte frequencies decreased over time (Fig. 4D). In parallel, decelerating
signaling trajectories were observed along the Janus kinase (JAK)–STAT and myeloid
differentiation primary response 88 (MyD88) signaling pathways in both innate and adaptive
immune cells (fig. S4). This decelerating behavior was particularly pronounced in innate
immune cells, as illustrated by the pSTAT1 signal in CD56dimCD16+ NK cells and the
pSTAT6 signal in DCs in response to IFN-α (Fig. 4, G and J), the phosphorylated cyclic
adenosine monophosphate response element–binding protein (pCREB) response in ncMCs
in response to GM-CSF (fig. S4), and the phosphorylated P38 mitogen-activated protein
kinase (pP38), phosphorylated extracellular signal–regulated kinase (pERK) and pCREB
signals in classical monocytes (cMCs) in response to LPS and GM-CSF (fig. S5). During the
100 days preceding labor, proinflammatory innate immune cell responses first increased, in
accordance with their previously described trajectory during the first and second trimesters
(12), and then stagnated or decreased closer to the day of labor. These findings indicate a
regulated dampening of systemic immune cell responses before the day of labor that may
counterbalance the local inflammatory environment emerging at the fetal membranes,
cervix, and fetomaternal interface during labor and parturition (46).
A breakpoint defined by nonlinearity of omic trajectories demarcates a transition from
pregnancy to prelabor biological adaptations

Author Manuscript

The presence of degree 2 (quadratic) trajectories across all omic datasets pointed toward a
period of disruption with approaching labor that resonated across all measured biological
systems (Fig. 4, E to J). Identifying the timing of such a nonlinear transition is clinically
relevant because it defines when the assessment of peripheral blood analytes is linked to
prelabor biology rather than a reflection of the biology relevant for the maintenance of
pregnancy. A piecewise fused LASSO regression analysis was used to provide an estimate as
to when before the day of labor such a transition occurs (Fig. 5A). This approach (see
Materials and Methods) combined the predictions rho (ρ) of two LASSO regression models
built using the data points before or after a given TL threshold, while varying the threshold
across all time points. A maximum ρ value was reached when the models on each side of the
threshold contained distinct yet top informative biological features that, when combined,
reached maximal predictive accuracy. The piecewise fused LASSO regression analysis
produced a maximum at 23 days before the day of labor (range [−27, −13] days; ρ at −23
days = 0.95; Fig. 5B).

Author Manuscript

Our results indicate that the maternal metabolome, proteome, and immunome undergo a
marked transition from maintenance of pregnancy to a phase of prelabor biology that is
linked to the timing of labor (Fig. 5C). The model in Fig. 5C summarizes major
characteristics of the biology before and after the transition period occurring 2 to 4 weeks
before labor.

DISCUSSION
This study combined the high-content assessment of circulating plasma factors with singlecell analyses of peripheral immune cells to survey dynamic changes in the maternal
metabolome, proteome, and immunome preceding the day of labor. Using a stringent
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analytical method that accounts for the dimensionality and heterogeneity of the data, we
built and independently validated a multiomic model that predicted the timing of
spontaneous labor.

Author Manuscript

Current efforts to monitor biological adaptations during pregnancy have primarily been
focused on investigating dynamics that differentiate normal from pathological pregnancies
on the basis of GA (12, 13, 47–53). Although they are informative in characterizing
pathological deviations during pregnancy, these approaches provide limited information for
the prediction of timing of labor because they rely on estimates of GA, which are imposed
by human assumption rather than based on biological determination. In contrast, our study
paradigm did not use an estimate but an observed outcome, such as the time to spontaneous
labor. This outcome was independent of GA on the basis of EDD and accounted for the
inherent variations in pregnancy duration. Hence, our approach enabled characterization of
labor-relevant pathways, which may be important for the identification of labor-specific
mechanisms in normal and pathological pregnancies.
In our study, the analysis of metabolic, proteomic, and immunologic trajectories provided an
integrated view of response mechanisms associated with the TL. Two major themes evolved:
(i) The coordinated adaptations across biological systems revealed a prelabor interactome
that pointed toward cross-talk between circulating plasma factors and immune cell responses
toward the end of pregnancy, and (ii) dynamics in omic trajectories uncovered a marked
transition from pregnancy maintenance to prelabor biology 2 to 4 weeks before delivery.

Author Manuscript

Aspects of our analysis agree with prior studies of endocrine and inflammatory changes
during late pregnancy. For example, steroid hormone metabolites were among the most
informative metabolic features of the predictive model, which is consistent with the
established role of progesterone in the maintenance of mammalian pregnancy (54) and the
progression to labor (20, 54, 55). Similarly, key immune response features of our predictive
model are consistent with previous studies reporting on peripheral immune activation with
approaching labor (12, 17, 56–63). Specifically, the pSTAT1 signaling in CD56dimCD16+
NK cells in response to IFN-α was a key immune feature common to our current model
predicting the TL and our previous model predicting GA (12). In contrast, the endogenous
STAT5 signaling activity in T cells, important for predicting GA (12), did not contribute to
the current model (fig. S6). Differences in immune features between the two models likely
reflect the dynamic evolution of immune signatures throughout pregnancy and underpin that
the selection of predictive parameters depends on the window of observation.

Author Manuscript

Our results also suggest previously undescribed cross-talk between metabolic, proteomic,
and immune cell features that precedes the onset of labor. We found that the surge in steroid
hormone metabolites 2 to 4 weeks before labor coincided with dynamic changes in plasma
protein concentrations and immune cell responses that reflected a previously unrecognized
switch from immune activation to regulation of inflammatory responses. One of the most
pronounced examples of immune regulation was the surge in the concentration of IL-1R4,
which paralleled the dampening of JAK-STAT and MyD88 responses in innate immune cells
(Fig. 4, F and J). The data suggest that IL-1R4, an IL-33 antagonist, may play a prominent
regulatory role during the prelabor phase by neutralizing IL-33 (64), a proinflammatory yet
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regulatory T cell–stabilizing alarmin released upon tissue remodeling (42). In mice, IL-33
has been assigned a pregnancy-maintaining role (43). Rising concentrations of IL-1R4 in
response to increased IL-33 activity could function as a labor-initiating signal by disrupting
IL-33–mediated mechanisms of fetomaternal tolerance (11, 19), while simultaneously
counteracting systemic proinflammatory innate responses to accumulating circulating fetal
material with approaching parturition (13, 65–68).

Author Manuscript

The observed dampening of systemic inflammatory events with approaching labor contrasts
with prior studies showing increased local inflammation of the cervix, decidua, fetal
membranes, and placenta during labor and parturition (46, 69, 70), although several other
studies of systemic immune responses during pregnancy echo our findings of decreased
peripheral immune cell responses with approaching labor (47, 56, 57, 60, 71, 72). Hence, the
systemic dampening of proinflammatory responses may be important to keep in check
proinflammatory events initiated locally with labor onset.

Author Manuscript

Our multiomic analysis also provided a high-resolution fingerprint of essential biological
processes preceding the day of labor, including changes in vascular development, placental
biology, and fetal membrane activation (22, 73). Angiogenic factors, potentially involved in
placental vascularization, progressively diminished (35, 36, 45); whereas, coagulation
capacity became enhanced (16, 17, 44). In accordance with previous studies (16, 25, 74, 75),
placental factors Activin-A and Siglec-6 followed accelerated trajectories, potentially
reflecting placental aging (32). Increased concentrations of serum Activin-A and placental
Siglec-6 are also detected in labor versus nonlabor deliveries (76–78). In addition, the steady
increase of epithelial factors PLXB2 and DDR1 likely mirrors the remodeling of the fetal
membranes (22). Several of these circulating proteins, including Angiopoietin-2, urokinasetype plasminogen activator (uPA), Activin-A, Siglec-6, PLXB2, and DDR1, have proven to
be informative model components for the prediction of GA, both by our group (79) and
others (16, 17).

Author Manuscript

The pathway enrichment analysis of the most informative model features provided further
insight on previously undescribed biological pathways implicated in the transition from
progressing pregnancy to labor onset. First, glycoproteins and proteins associated with
glycoprotein metabolism, including ATIII, VEGF121, matrix metalloproteinase 12
(MMP12), Angiopoietin-2, sTie-2, and SLIT and NTRK-like protein 5 (SLITRK5), were
enriched among the proteomic features. SLITRK5 has a high affinity for pregnancy-specific
glycoprotein (80), an immune tolerance–enhancing protein released from the placenta and
peaking in late gestation (81). Second, metabolic pathways, including tryptophan
metabolism, and pentose/glucuronate interconversions (carbohydrate metabolism) were also
enriched. The systemic concentration of serotonin-precursor 5-hydroxytryptophan is a proxy
for serotonin activity in the central nervous system and facilitates vasoconstriction in the
placenta (82, 83). The involvements of glycoproteins, vasoactive neurotransmitters, and
energy metabolism highlight prelabor dynamics beyond previously described fetal and
immunoendocrine mechanisms.
Our study has certain limitations. First, the cohort included a homogeneous population of
women recruited at a single center, who went into labor predominantly at term (N = 63; of
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which five preterm < 37 weeks, zero postterm > 42 weeks). Hence, our model predicted the
TL in term and preterm pregnancies with similar accuracy. Future studies in a more diverse
population and enriched for women with extreme pregnancy lengths will be needed to
further test the generalizability of our findings. Studies specifically focusing on women with
preterm labor will be particularly important because the ability to predict labor several
weeks before the actual day of labor provides a critical time window that would aid in
clinical decision-making for the early management of a patient at risk of preterm labor. In
such studies, it will also be important to refine the predictive models to allow differentiating
between labor onset that results in arrested preterm labor versus resulting in a preterm
delivery, which our current model cannot resolve. Further, future studies will be required to
determine the effect of pregnancy complications such as preeclampsia, chorioamnionitis, or
infection on the predictive model parameters reported here. Second, we limited the blood
sampling frequency to three samples per patient. Nonetheless, our approach provided highly
informative results regarding multiomic adaptations relevant to the TL, which will dovetail
with other studies, generating less data with higher per-patient sampling resolution (84).
Third, our study lacks the assessment of local immune responses. It will be informative to
determine the relationship between systemic and local features occurring before and during
labor. Last, interactions between features identified within and between datasets remain
associations until supported by direct mechanistic evidence. However, on the basis of prior
biological knowledge, particular associations between proteins or metabolites and immune
cell responses can be hypothesized to be biological interactions.

Author Manuscript

In summary, determining the timing of labor and delivery, and predicting preterm and
postterm pregnancy risk, remains an important clinical challenge. The biological insights of
this study may guide therapeutic approaches to extend pregnancy when the labor signature is
detected early (preterm birth) or to accelerate labor processes to avoid the need for induction
of labor in postdate pregnancies. The results lay the foundation to examine prelabor biology
for the development of a universal diagnostic tool that can predict the TL.

MATERIALS AND METHODS
Study design

Author Manuscript

The aim of this observational study was to determine a precise chronology of pregnancyrelated metabolomic, proteomic, and immunologic adaptations in venous blood samples
collected serially during the last 100 days of pregnancy. The study was conducted at the
Lucile Packard Children’s Hospital (Stanford, CA, USA) and approved by the Institutional
Review Board (approval ID, 40105). All participants signed an informed consent. Healthy
pregnant women receiving routine antepartum care were eligible for the study if they were
within 18 to 50 years of age, had a BMI < 40 in their second or third trimester of pregnancy
as determined by their clinician using LMP and ultrasound estimates of GA, and had no
immune-modifying comorbidities or medication usage. Participants were followed
longitudinally until parturition, collecting one to three blood samples throughout the third
trimester. In total, 112 women were recruited to meet the predetermined sample size
required for sufficient power in this longitudinal study. Participants for whom labor was
medically induced (N = 43) or who underwent cesarean section without labor (N = 4) were
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excluded. Two participants dropped out of the study. Participants with singleton pregnancies,
who went into spontaneous labor (N = 53 training cohort, N = 5 test cohort) or experienced
spontaneous rupture of membranes before labor onset (N = 5 test cohort) were included in
the analysis. The day of labor was defined as day of admission for spontaneous labor
(contractions occurring at least every 5 min, lasting >1 min, and associated with cervical
change). For five patients from the test cohort, the day of spontaneous rupture of membrane
was designated as the day of labor because labor would have likely ensued spontaneously
(85), but modern clinical care required induction of labor for these patients. The GA at day
of sampling was based on the clinical EDD established by LMP and/or ultrasonographic
assessment according to the American College of Obstetricians and Gynecologists
committee opinion (8). Researchers conducting the analyses were not blinded.
Randomization was not applicable to this study. Demographics, pregnancy characteristics,
and comorbidities for the 63 participants included in the analysis are summarized in Table 1.

Author Manuscript

Mass cytometry from whole blood
Ex vivo immunoassay—Whole blood was collected from study subjects and processed
within 60 min after blood draw. Individual aliquots were stimulated for 15 min at 37°C with
LPS (1 μg/ml; InvivoGen, San Diego, CA), IFN-α (100 ng/ml; PBL Assay Science,
Piscataway, NJ), GM-CSF (100 ng/ml; R&D Systems, Minneapolis, MN), and a cocktail of
IL-2, IL-4, and IL-6 (each 100 ng/ml; R&D Systems) or left unstimulated. Samples were
processed using a standardized protocol for fixing with proteomic stabilizer (SMART TUBE
Inc., San Carlos, CA) and stored at −80°C until further processing.

Author Manuscript
Author Manuscript

Mass cytometry and derivation of cell frequency, basal intracellular signaling,
and intracellular signaling response features—Forty-one innate and adaptive
immune cell subsets were identified using a 45-parameter mass cytometry antibody panel
and according to the gating strategy in fig. S7. Cell frequencies were expressed as a
percentage derived from singlet live mononuclear cells (DNA+cPARP−
CD235−CD61−CD66−) except for granulocyte frequencies, which were expressed as a
percentage of singlet live leukocytes (DNA+cPARP− CD235−CD61−). Endogenous
intracellular signaling activities at the basal, unstimulated state were quantified per single
cell for pSTAT1, pSTAT3, pSTAT5, pSTAT6, pCREB, pMK2, pERK, phosphorylated S6
ribosomal protein (prpS6), pP38, and phosphorylated nuclear factor κB (pNF-κB), and total
inhibitor of NF-κB (IκB) using an arcsinh-transformed value calculated from the median
signal intensity. Intracellular signaling responses to stimulation were reported as the
difference in arcsinh-transformed value of each signaling protein between the stimulated and
unstimulated conditions (arcsinh ratio over endogenous signal). A knowledge-based
penalization matrix was applied to intracellular signaling response features in the mass
cytometry data based on mechanistic immunological knowledge, as previously described
(14, 86). Mechanistic priors used in the penalization matrix are independent of
immunological knowledge related to pregnancy or the day of labor.
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Derivation of proteomic (SomaLogic Inc., Boulder, CO) and metabolomic (liquid
chromatography–mass spectrometry) features from plasma samples is described in the
Supplementary Materials.
Statistical analyses

Author Manuscript

Multivariate modeling and SG—For a matrix X of all biological features from a given
omic dataset, and a vector of days to day of labor Y, the LASSO algorithm calculates
coefficients β to minimize the error term L(β) = ∥Y − Xβ∥2. An L1 regularization was used
to increase model sparsity for the sake of biological interpretation and model validation.
Once a LASSO model was trained for each omics modality, the multiomic analysis was
carried out by performing SG on the new representation of the data by using the outputs of
the previous layer of models as predictors. A LASSO model was first constructed on each
omic modality. Then, all estimations of TL were used as predictors for a second-layer
LASSO model. Intrinsically, this is equivalent to a weighted average of the individual
models with the coefficients of the LASSO model as desired weights. A two-layer leaveone-subject-out cross-validation strategy was used to assess the generalizability of the SG
model built on the training cohort (see the Supplementary Materials). Performance for
training and validation was evaluated using RMSE, and the test statistic is based on
Pearson’s product moment correlation coefficient. The asymptotic confidence interval is
given on the basis of Fisher’s Z transform.

Author Manuscript

Piecewise fused LASSO regression—To identify a possible “switch point” before
labor, we used two sequential LASSO models applied to all samples before/after a given
threshold. Cross-validation predictions from both models were combined to develop a joint
goodness-of-fit score for the entire dataset. The threshold was varied across the dataset to
identify the point with the best fit for the combined models. Fused LASSO (87, 88), a
generalized LASSO for one-dimensional sequential data, which penalizes the absolute
differences in successive coordinates of the LASSO coefficients, was used to detect the
interval in which the joint models had the strongest predictive power, representing the region
where the maximal change of biological behavior occurs before delivery.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. The maternal metabolome, proteome, and immunome were assessed during the 100-day
period preceding the day of labor.

Author Manuscript

(A) Peripheral blood was obtained serially from 63 women during the 100 days preceding
spontaneous labor. The primary outcome of the analysis was the time to labor (TL), such
that the prediction of the day of labor did not consider estimates of GA. Raster plots
depicting the day of sampling for the training (top plot; N = 53, n = 150 samples) and test
(bottom plot; N = 10, n = 27 samples) cohort, and the TL distribution (range [−112, 0]),
calculated as the difference between the day of labor (TL 0, red line) and the day of
sampling (filled dots). At least one sample was collected on any day of the 100 days
preceding the day of labor (cumulative count plot). (B) Plasma samples were used in the
analysis of the circulating metabolome (high-throughput mass spectrometry) and proteome
(aptamer-based technology). Whole-blood samples were used in the analysis of the systemic
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immunome (mass cytometry). In total, 7142 features were generated per sample from all
three datasets and integrated into a multivariate model to predict the TL.
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Fig. 2. The late-gestational maternal interactome highlights interconnectivity between biological
systems.
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(A to C) Intraomic correlation networks of metabolome, proteome, and immunome features
during the 100 days preceding labor in the training cohort (N = 53). Each node represents a
biological feature. Correlations between features are represented by edges. Red/blue nodes
highlight features positively/negatively correlated with the TL. Dot size indicates the −log10
of P value of the correlation (Spearman). Clusters of features most highly correlated with the
TL are shaded in gray and annotated. (D) Distributions of all correlations within (intraomic)
and between (interomic) modalities in the original as well as simulated random datasets. The
false discovery rate (FDR) threshold of 0.05 was computed from the generated distribution
of random features in a target-to-decoy approach to filter the correlations with FDR > 0.05,
corresponding to an absolute (|x|) correlation coefficient cutoff at 0.46. (E) Chord diagram of
interomic (between-dataset) correlations between metabolome, proteome, and immunome
features in the last 100 days before the day of labor. The outer circle represents all features
with FDR-adjusted absolute correlation coefficients [Spearman R (0.46, 1.0), FDR < 0.05],
colored by the respective biological modality. Shaded inner connections represent interomic
correlations between the metabolome, proteome, and immunome as specified by color
codes. The number of FDR-adjusted interactions between two omics is visualized as
normalized to the number of total possible interomic interactions. (F) Quantification of the
number of interomic interactions visualized in (E). The number of interomic correlations
between the three biological modalities divided into weak (0.46 to 0.6), moderate (0.6 to
0.8), and strong (0.8 to 1.0) absolute correlation coefficients is shown.

Sci Transl Med. Author manuscript; available in PMC 2021 May 20.

Stelzer et al.

Page 23

Author Manuscript
Author Manuscript
Author Manuscript

Fig. 3. Multiomic modeling of the maternal interactome predicts labor onset.
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(A) Integration of all three modalities (metabolome, proteome, and immunome) using a
stacked generalization (SG) method. (B and C) Regression of predicted versus true TL
(days) derived from the SG model [training cohort, Pearson R = 0.85, 95% CI [0.79 to 0.89],
P = 1.2 × 10−40, RMSE = 17.7 days, N = 53 patients (B); test cohort, Pearson R = 0.81, 95%
CI [0.61 to 0.91], P = 3.9 × 10−7, RMSE = 17.4 days, N = 10 patients (C)]. (D) Volcano plot
depicting the 45 most informative SG model features in the training cohort. Feature
importance to the overall predictive model is plotted on the x axis (SG model coefficient),
correlation with the TL is plotted on the y axis [−Log10 (P value)]. Orange colors depict
positive correlations with the TL, and teal colors depict negative correlations. See table S3
for number-to-feature key. (E) Pathway enrichment analysis was performed on metabolic
and proteomic top SG model features (see Materials and Methods; P values derived from
hypergeometric and Fisher’s test). All 45 most informative model features are depicted in a
correlation network to visualize interomic correlations (edges indicate an absolute R > 0.46,
N = 53). See also Fig. 4, fig. S1, and table S3.
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Fig. 4. Trajectories of the maternal metabolome, proteome, and immunome reveal alterations in
prelabor dynamics.
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(A) Distribution of relevance-of-fit P values for the trajectories assigned to SG model
features in comparison to nonselected features demonstrates goodness of fit of curve
classification (N = 53 patients, n = 150 samples). Feature trajectories were classified as
linear or quadratic on the basis of the goodness of fit with Akaike information criterion and
relevance of fit with associated P value (F statistic). Degree 1 (B to D), degree 2a (E to G),
or degree 2b (H to J) trajectories are plotted over time for the metabolome (left), proteome
(middle), and immunome (right). Lines represent smoothened spline (df = 3, Z-scored) for
all features. The most informative model features are highlighted and numbered (in
reference to Fig. 3D and table S3). A representative feature is shown (inset) for each
trajectory type including its correlation with TL (Spearman coefficient [95% CI], and
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associated P value). (K) Radar plot quantifying the distribution of degree 1 (linear), degree
2a [quadratic, accelerating (surging of an increasing or decreasing pattern over time)], and
degree 2b [quadratic, decelerating (plateauing of an increasing or decreasing pattern over
time)] trajectories among all multiomic features. See also figs. S2 to S6 and tables S3 and
S4.
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Fig. 5. A breakpoint in omic trajectories demarcates the transition from pregnancy maintenance
to prelabor biological adaptations.
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(A) Schematic of a piecewise fused LASSO regression combining predictions rho (ρ) of two
regression models built from all datasets before and after a particular TL threshold, while
sliding the threshold across the time axis. Plotting ρ over time reveals the time point of
highest accuracy (maximum ρ). (B) Maximum ρ of 0.95 was observed at day −23 (range
[−27, −13]; N = 53 patients). (C) Summary of concerted biological adaptations depicting a
clock to labor. Angiogenic factors: Decreased Angiopoietin-2, sTie-2, and VEGF121. Aging
fetal membranes: Increased PLXB2 and DDR1. Placental signaling: Increased Activin-A
and Siglec-6. Coagulation capacity: Decreased ATIII and increased uPA. Immune
responsiveness: Increased Cystatin C, increased pSTAT1 responses in NK and pDC upon
IFN-α stimulation, and decreased granulocyte frequencies. A switch to prelabor biology
occurs at day −23 (range [−27, −13]; pink shaded phase) before the day of labor. The
prelabor phase is characterized by immune regulation: Stagnating pSTAT1 responses in NK
and pDC upon IFN-α stimulation, decreased basal IκB and pMK2 signals in CD4+ and
CD8+ T cells, decreased pCREB in ncMC upon GM-CSF stimulation, decreased pSTAT6
responses in DC upon IFN-α stimulation, decreased pMK2 in B cells upon LPS stimulation,
and decreased MyD88 responses in cMC upon LPS and GM-CSF stimulation. Regulation of
Macrophage inhibitory cytokine-1 (MIC-1), Secretory Leukocyte Peptidase Inhibitor (SLPI),
and Lymphocyte-activation gene 3 (LAG3). Surging Cystatin C and IL-1R4. Endocrine
signaling: Surging 17-OHP isomers, 17-hydroxypregnenolone sulfate, and cortisol isomer.
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